IdentificationGeneric Name(2R)-N-{4-[Ethyl(phenyl)sulfamoyl]-2-methylphenyl}-3,3,3-trifluoro-2-hydroxy-2-methylpropanamideDrugBank Accession NumberDB08609BackgroundNot AvailableTypeSmall MoleculeGroupsExperimentalStructure


3DDownload MOLSDF3D-SDFPDBSMILESInChI


 Similar StructuresStructure for (2R)-N-{4-[Ethyl(phenyl)sulfamoyl]-2-methylphenyl}-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide (DB08609)× CloseWeightAverage: 430.441 Monoisotopic: 430.117412475 Chemical FormulaC19H21F3N2O4SSynonymsNot AvailablePharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionTargetActionsOrganismU[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 2, mitochondrialNot AvailableHumansAbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesNot AvailableChemical TaxonomyProvided by ClassyfireDescriptionThis compound belongs to the class of organic compounds known as sulfanilides. These are organic aromatic compounds containing a sulfanilide moiety, with the general structure RS(=O)(=O)NC1=CC=CC=C1.KingdomOrganic compoundsSuper ClassBenzenoidsClassBenzene and substituted derivativesSub ClassSulfanilidesDirect ParentSulfanilidesAlternative ParentsBenzenesulfonamides / Anilides / Benzenesulfonyl compounds / N-arylamides / Toluenes / Organosulfonamides / Tertiary alcohols / Aminosulfonyl compounds / Fluorohydrins / Secondary carboxylic acid amides / Organopnictogen compounds / Organofluorides / Organic oxides / Alkyl fluorides / Hydrocarbon derivatives / Carbonyl compounds


 show 6 moreSubstituentsAlcohol / Alkyl fluoride / Alkyl halide / Aminosulfonyl compound / Anilide / Aromatic homomonocyclic compound / Benzenesulfonamide / Benzenesulfonyl group / Carbonyl group / Carboxamide group / Carboxylic acid derivative / Fluorohydrin / Halohydrin / Hydrocarbon derivative / N-arylamide / Organic nitrogen compound / Organic oxide / Organic oxygen compound / Organic sulfonic acid or derivatives / Organofluoride / Organohalogen compound / Organonitrogen compound / Organooxygen compound / Organopnictogen compound / Organosulfonic acid amide / Organosulfonic acid or derivatives / Organosulfur compound / Secondary carboxylic acid amide / Sulfanilide / Sulfonyl / Tertiary alcohol / Toluene


 show 22 moreMolecular FrameworkAromatic homomonocyclic compoundsExternal DescriptorsNot AvailableAffected organismsNot AvailableChemical IdentifiersUNIINot AvailableCAS numberNot AvailableInChI KeySHEIQJGQDUYUBE-GOSISDBHSA-NInChIInChI=1S/C19H21F3N2O4S/c1-4-24(14-8-6-5-7-9-14)29(27,28)15-10-11-16(13(2)12-15)23-17(25)18(3,26)19(20,21)22/h5-12,26H,4H2,1-3H3,(H,23,25)/t18-/m1/s1IUPAC NameN-{4-[ethyl(phenyl)sulfamoyl]-2-methylphenyl}-3,3,3-trifluoro-2-hydroxy-2-methylpropanamideSMILES[H]N(C(=O)C(C)(O)C(F)(F)F)C1=C(C)C=C(C=C1)S(=O)(=O)N(CC)C1=CC=CC=C1ReferencesGeneral ReferencesNot AvailableExternal LinksPubChem Compound6102762PubChem Substance99445080ChemSpider4810270ZINCZINC000001547315PDBe LigandTF2PDB Entries2bu6Clinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourceWater Solubility0.00734 mg/mLALOGPSlogP3.17ALOGPSlogP3.58ChemaxonlogS-4.8ALOGPSpKa (Strongest Acidic)9.45ChemaxonpKa (Strongest Basic)-5.2ChemaxonPhysiological Charge0ChemaxonHydrogen Acceptor Count4ChemaxonHydrogen Donor Count2ChemaxonPolar Surface Area86.71 Å2ChemaxonRotatable Bond Count6ChemaxonRefractivity104.05 m3·mol-1ChemaxonPolarizability40.26 Å3ChemaxonNumber of Rings2ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterYesChemaxonVeber's RuleNoChemaxonMDDR-like RuleNoChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption+0.9928Blood Brain Barrier+0.6549Caco-2 permeable-0.5914P-glycoprotein substrateNon-substrate0.6355P-glycoprotein inhibitor INon-inhibitor0.6799P-glycoprotein inhibitor IIInhibitor0.6047Renal organic cation transporterNon-inhibitor0.9505CYP450 2C9 substrateNon-substrate0.5755CYP450 2D6 substrateNon-substrate0.8169CYP450 3A4 substrateNon-substrate0.5556CYP450 1A2 substrateNon-inhibitor0.7909CYP450 2C9 inhibitorInhibitor0.622CYP450 2D6 inhibitorNon-inhibitor0.8014CYP450 2C19 inhibitorInhibitor0.6414CYP450 3A4 inhibitorInhibitor0.6999CYP450 inhibitory promiscuityHigh CYP Inhibitory Promiscuity0.696Ames testNon AMES toxic0.689CarcinogenicityNon-carcinogens0.5138BiodegradationNot ready biodegradable1.0Rat acute toxicity2.3824 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.9974hERG inhibition (predictor II)Non-inhibitor0.7613  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraSpectrumSpectrum TypeSplash KeyPredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableTargetsBuild, predict & validate machine-learning modelsUse our structured and evidence-based datasets to unlock newinsights and accelerate drug research.Learn more  Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.Learn more


 Details1. [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 2, mitochondrialKindProteinOrganismHumansPharmacological actionUnknownGeneral FunctionPyruvate dehydrogenase (acetyl-transferring) kinase activitySpecific FunctionKinase that plays a key role in the regulation of glucose and fatty acid metabolism and homeostasis via phosphorylation of the pyruvate dehydrogenase subunits PDHA1 and PDHA2. This inhibits pyruvat...Gene NamePDK2Uniprot IDQ15119Uniprot Name[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialMolecular Weight46153.39 DaReferencesBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] ×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at September 15, 2010 21:33 / Updated at June 12, 2020 16:52 